0001209191-21-011775.txt : 20210218 0001209191-21-011775.hdr.sgml : 20210218 20210218160018 ACCESSION NUMBER: 0001209191-21-011775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lundberg Sven Ante CENTRAL INDEX KEY: 0001682126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 21649427 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-16 0 0001651311 Merus N.V. MRUS 0001682126 Lundberg Sven Ante C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM NETHERLANDS 1 1 0 0 President, CEO & PFO Share Option (right to buy) 24.43 2021-02-16 4 A 0 368000 0.00 A 2031-02-16 Common Shares 368000 368000 D Options vest over a four-year period from January 1, 2021. 25% vest on January 1, 2022 and in 36 equal monthly installments thereafter. /s/ Peter Silverman as attorney-in-fact 2021-02-18